Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MTX1 | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-09 |
mRNA | MRPL24 | CTRPv2 | pan-cancer | AAC | -0.21 | 6e-09 |
mRNA | THEM4 | CTRPv2 | pan-cancer | AAC | -0.2 | 6e-07 |
mRNA | DAP3 | CTRPv2 | pan-cancer | AAC | -0.2 | 8e-08 |
mRNA | RAB13 | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-06 |
mRNA | MRPL9 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-07 |
mRNA | SHC1 | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-07 |
mRNA | HDLBP | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
mRNA | GPATCH4 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-07 |
mRNA | BAG3 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-05 |